| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |